Daylette 0.02mg/3mg tablets United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

daylette 0.02mg/3mg tablets

consilient health ltd - drospirenone; ethinylestradiol - oral tablet - 3mg ; 20microgram

DAYLETTE 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos Andorra - English - CedimCat (Centre d'Informació de Medicaments de Catalunya)

daylette 3 mg/ 0,02 mg comprimidos recubiertos con pelicula efg , 28 comprimidos

DAYLETTE 3 mg/ 0,02 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 84 (3 x 28) compri Andorra - English - CedimCat (Centre d'Informació de Medicaments de Catalunya)

daylette 3 mg/ 0,02 mg comprimidos recubiertos con pelicula efg , 84 (3 x 28) compri

Daylette 0,02 mg - 3 mg film-coat. tabl. Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

daylette 0,02 mg - 3 mg film-coat. tabl.

gedeon richter plc - drospirenone 3 mg (white tablet); ethinylestradiol 0,02 mg (white tablet); placebo (green tablet) - film-coated tablet - 0,02 mg - 3 mg - drospirenone 3 mg; ethinylestradiol 0.02 mg; placebo - drospirenone and ethinylestradiol

Daylette 0,02 mg/3 mg Filmtabletten Germany - English - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

daylette 0,02 mg/3 mg filmtabletten

VALETTE ethinyloestradiol / dienogest tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

valette ethinyloestradiol / dienogest tablet blister pack

bayer australia ltd - dienogest, quantity: 2 mg; ethinylestradiol, quantity: 0.03 mg - tablet, sugar coated - excipient ingredients: calcium carbonate; ferric oxide; macrogol 6000; glycol montanate; glycerol; sucrose; lactose monohydrate; maize starch; povidone; titanium dioxide; purified talc; magnesium stearate - valette is indicated for use as an oral contraceptive and in the treatment of mild to moderate acne in women who seek oral contraception.

VALETTE Australia - English - Department of Health (Therapeutic Goods Administration)

valette

bayer australia ltd - ethinyloestradiol; dienogest -

Palette Life Sciences DEFLUX Gel for Injection Singapore - English - HSA (Health Sciences Authority)

palette life sciences deflux gel for injection

transmedic pte ltd - gastroenterology & urology - intended for submucosal injections in the urethra, urinary bladder and distal ureter. indication for use (1) vesicoureteral reflux (2) stress urinary incontinence due to urethral sphincter incompetence. deflux may also be effective for stress urinary incontinence due to urethral hypermobility

Palette DEFLUX metal needle Singapore - English - HSA (Health Sciences Authority)

palette deflux metal needle

transmedic pte ltd - gastroenterology & urology - intended for submucous injection of deflux® gel in the urinary tract.

Barrigel - Radiotherapy protection spacer Australia - English - Department of Health (Therapeutic Goods Administration)

barrigel - radiotherapy protection spacer

palette life sciences australia pty ltd - 60424 - radiotherapy protection spacer - barrigel is a sterile, transparent, biodegradable gel of stabilized hyaluronic acid of non-animal origin, supplied in a glass syringe. barrigel acts by adding volume to the tissue, thereby mechanically creating an increased distance between the prostate and the anterior rectal wall. the product degrades over time. barrigel is used to increase the distance between the prostate and the anterior rectal wall, with the intent to decrease radiation dose delivered to the rectum when treating prostate cancer with radiation.